AKT1 and prostate carcinoma: As shown in Figure 3A (left panel), Ang-1 induced a dose-dependent increase in AKT phosphorylation, a direct downstream target of the Ang-1/Tie-2 signalling pathway, confirming that Tie-2 activates prostate cancer cells.